Therapeutic expertise

Diabetes & Endocrinology Clinical Trial Sites

WCR evaluates diabetes, glucose-management, and endocrine protocols through established clinical relationships, bilingual patient engagement, and coordinated site operations.

Program fit

Longitudinal patient relationships for chronic-disease research

Private-practice access may support identification and follow-up of participants living with diabetes and related metabolic conditions. WCR confirms protocol, investigator, equipment, laboratory, and recruitment fit before acceptance.

  • Type 2 diabetes
  • Glucose management
  • Insulin resistance
  • Endocrine conditions
  • Diabetes-related metabolic risk
  • Weight and glucose-related research

Site resources

  • Clinical sample processing
  • Temperature-controlled storage
  • Calibrated scales and vital-sign equipment
  • Local laboratory access
  • Bilingual retention support

From our case studies

Obesity and diabetes: moving from screening to randomization

The team screened 27 people during the first month after activation. Thirteen were subsequently randomized after the protocol’s screening period. The case explains the work between those two milestones.

≤1week: activation to first screening
27screened in the first month
13subsequently randomized
Read the full study story

For sponsors & CROs

Diabetes feasibility starts with the clinical details

WCR evaluates diabetes and endocrinology clinical trials through investigator experience, established patient relationships and protocol-specific review of medical and medication requirements. Its obesity-with-diabetes case study describes preparing additional staffing before startup, early prescreening and continued engagement between screening and randomization. This provides a concrete example of patient access and operational capacity being planned together.

From feasibility to study visits

  1. Review medical and medication eligibility against the protocol with the clinical team.

  2. Match anticipated screening activity with staffing and appointment capacity.

  3. Keep participants connected while coordinating study visits, outside assessments and counseling.

Relevant investigator experience

Clinical experience behind the feasibility review

Miami Lakes, Florida

Lucky Flores, MD

Research experience across GI, dermatology, obesity, diabetes, respiratory disease, vaccines and women’s health.

Puerto Rico

Gustavo R. Albizu-Angulo, MD

Research experience in obesity, diabetes, cardiovascular risk, inflammatory bowel disease, vaccines, asthma and migraine.

Puerto Rico

Susane G. Santos Marrero, MD

Research experience in obesity, type 2 diabetes, cardiovascular risk, eosinophilic asthma and vaccines.

Investigator assignment, location suitability and study-specific resources are confirmed during feasibility. Explore both research locations

Related network experience

The work behind the study results

Phase 3b

Obesity and weight maintenance

Patients from the investigator’s private practice formed the candidate pool. Early prescreening and engagement helped recruitment move forward while WCR coordinated research visits, outside assessments, and counseling.

Review this case study

For participants

Explore diabetes and endocrine studies

The research team will review the purpose of a study, eligibility, visits, procedures, and participant protections with you before you decide.

View Enrolling Trials

Related expertise

Connected therapeutic areas

Evaluate a diabetes or endocrinology protocol